Halozyme Therapeutics Inc (NASDAQ:HALO)

15.07
Delayed Data
As of Feb 27
 -0.21 / -1.37%
Today’s Change
6.88
Today|||52-Week Range
15.94
+56.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues12.5M12.0M18.4M14.6M
 
 
 
 
 
Cost of Goods Sold3.2M5.1M5.5M4.7M
 
 
 
 
 
Depreciation And Amortization333.5K397.0K443.0K464.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.0M6.4M12.5M9.5M
 
 
 
 
 
General Expenses30.3M31.7M27.4M28.5M
 
 
 
 
 
Research And Development20.9M21.4M18.6M19.9M
 
 
 
 
 
Total Operating Expenses33.8M37.2M33.3M33.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.3M-25.2M-14.9M-19.0M
 
 
 
 
 
Interest Expense On Debt727.6K1.4M1.5M1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.0M-26.5M-16.3M-20.3M
 
 
 
 
 
Net Income-22.0M-26.5M-16.3M-20.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS113.6M118.9M123.7M124.0M
 
 
 
 
 
Shares To Calculate EPS Diluted113.6M118.9M123.7M124.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.22-$0.13-$0.16
 
 
 
 
 
EPS Diluted-$0.19-$0.22-$0.13-$0.16
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account